Sally George
0000-0003-2777-4922
4 papers found
Refreshing results…
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Missing publications? Search for publications with a matching author name.